Session Information

WCLC 2021

2022 World Conference on Lung Cancer
Presentation Date(s):
- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)

PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
Register to Attend WCLC Login to WCLC2021 Switch to Virtual Meeting
Enter Virtual Meeting Access Code

All Days Wednesday
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14

Filter Results:

Show Only CME Accredited Sessions

38243

+
MTE04 - Meet the Expert - Thoracic Cancers Research and Resource Disparities among Geographic Regions
- 05:15 - 06:15
- 9/09/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Laura Mezquita
- 38268
  
  +
  
  MTE04.01 - Thoracic Cancers Research and Resource Disparities among Geographic Regions
  
  05:15 - 06:15 | Presenter: David Harpole
  Abstract
  
  No abstract available for this presentation
37987

+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
- 37163
  
  +
  
  PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
  
  06:30 - 06:40 | Presenter: Melissa L Johnson
  Abstract
  
  Loading...
- 38305
  
  +
  
  PL02.02 - Discussant
  
  06:40 - 06:47 | Presenter: Julie Brahmer
  Abstract
  
  No abstract available for this presentation
- 37405
  
  +
  
  PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
  
  06:47 - 06:57 | Presenter: Luis Paz-Ares
  Abstract
  
  Loading...
- 38306
  
  +
  
  PL02.04 - Discussant
  
  06:57 - 07:04 | Presenter: Charles M Rudin
  Abstract
  
  No abstract available for this presentation
- 38263
  
  +
  
  PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
  
  07:04 - 07:14 | Presenter: Nasser Altorki
  Abstract
  
  Loading...
- 38307
  
  +
  
  PL02.06 - Discussant
  
  07:14 - 07:21 | Presenter: Ichiro Yoshino
  Abstract
  
  No abstract available for this presentation
- 37116
  
  +
  
  PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution
  
  07:21 - 07:31 | Presenter: Christine Dorothy Berg
  Abstract
  
  Loading...
- 38308
  
  +
  
  PL02.08 - Discussant
  
  07:31 - 07:38 | Presenter: Joachim G.J.V. Aerts
  Abstract
  
  No abstract available for this presentation
- 37222
  
  +
  
  PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
  
  07:38 - 07:48 | Presenter: Matthew Smeltzer
  Abstract
  
  Loading...
- 38309
  
  +
  
  PL02.10 - Discussant
  
  07:48 - 07:55 | Presenter: Marina Chiara Garassino
  Abstract
  
  No abstract available for this presentation
- 38310
  
  +
  
  PL02.11 - Live Discussion with Speakers
  
  07:55 - 08:00
  Abstract
  
  No abstract available for this presentation
38001

+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- 14:30 - 16:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
- 38288
  
  +
  
  PL02A.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
  
  14:30 - 14:40 | Presenter: Melissa L Johnson
  Abstract
  
  Loading...
- 38311
  
  +
  
  PL02A.02 - Discussant
  
  14:40 - 14:47 | Presenter: Julie Brahmer
  Abstract
  
  No abstract available for this presentation
- 38289
  
  +
  
  PL02A.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
  
  14:47 - 14:57 | Presenter: Luis Paz-Ares
  Abstract
  
  Loading...
- 38312
  
  +
  
  PL02A.04 - Discussant
  
  14:57 - 15:04 | Presenter: Charles M Rudin
  Abstract
  
  No abstract available for this presentation
- 38290
  
  +
  
  PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
  
  15:04 - 15:14 | Presenter: Nasser Altorki
  Abstract
  
  Loading...
- 38313
  
  +
  
  PL02A.06 - Discussant
  
  15:14 - 15:21 | Presenter: Ichiro Yoshino
  Abstract
  
  No abstract available for this presentation
- 38291
  
  +
  
  PL02A.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution
  
  15:21 - 15:31 | Presenter: Christine Dorothy Berg
  Abstract
  
  Loading...
- 38314
  
  +
  
  PL02A.08 - Discussant
  
  15:31 - 15:38 | Presenter: Joachim G.J.V. Aerts
  Abstract
  
  No abstract available for this presentation
- 38292
  
  +
  
  PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
  
  15:38 - 15:48 | Presenter: Matthew Smeltzer
  Abstract
  
  Loading...
- 38315
  
  +
  
  PL02A.10 - Discussant
  
  15:48 - 15:55 | Presenter: Marina Chiara Garassino
  Abstract
  
  No abstract available for this presentation
- 38316
  
  +
  
  PL02A.11 - Live Discussion with Speakers
  
  15:55 - 16:00
  Abstract
  
  No abstract available for this presentation
38096

+
WS02 - Early Career Workshop
- 11:30 - 13:00
- 9/11/2021
- Location: Program Auditorium
- Not for CME Credit
- Type: Workshop
- Track: N.A.
- Moderators:Thomas E. Stinchcombe, Kristin A Higgins, David Harpole
- 38112
  
  +
  
  WS02.01 - Introduction
  
  11:30 - 11:35 | Presenter: David Harpole, Kristin A Higgins, Thomas E. Stinchcombe
  Abstract
  
  No abstract available for this presentation
- 38106
  
  +
  
  WS02.02 - How to Maximize Success in Publications for JTO - Writing a Compelling Manuscript
  
  11:35 - 11:45 | Presenter: Emily Stone, Cheryl Ho
  Abstract
  
  Loading...
- 38107
  
  +
  
  WS02.03 - How to Create Your First Clinical Trial
  
  11:45 - 11:55 | Presenter: Kristin A Higgins, Salma K Jabbour
  Abstract
  
  No abstract available for this presentation
- 38108
  
  +
  
  WS02.04 - How to Create Programmatic Growth in the Community Setting
  
  11:55 - 12:05 | Presenter: Luis E. Raez
  Abstract
  
  No abstract available for this presentation
- 38109
  
  +
  
  WS02.05 - How to Move to Different Positions/Areas of Practice/Research? How to Pivot Within Your Career?
  
  12:05 - 12:15 | Presenter: Mark A. Socinski
  Abstract
  
  No abstract available for this presentation
- 38110
  
  +
  
  WS02.06 - How to Get Promoted
  
  12:15 - 12:25 | Presenter: Taofeek Owonikoko
  Abstract
  
  No abstract available for this presentation
- 38111
  
  +
  
  WS02.07 - How to Establish International Collaborations/Navigating Large International Trials
  
  12:25 - 12:35 | Presenter: Tom Treasure
  Abstract
  
  No abstract available for this presentation
- 38113
  
  +
  
  WS02.08 - Breakout Rooms for Each Topic
  
  12:35 - 13:00 | Presenter: Emily Stone, Cheryl Ho, Kristin A Higgins, Salma K Jabbour, Luis E. Raez, Mark A. Socinski, Vassiliki Papadimitrakopoulou, Taofeek Owonikoko, David Harpole, Tom Treasure, Marina Chiara Garassino, Marie Suga
  Abstract
  
  No abstract available for this presentation

Session Information

WCLC 2021

2022 World Conference on Lung Cancer

Enter Virtual Meeting Access Code

+

MTE04 - Meet the Expert - Thoracic Cancers Research and Resource Disparities among Geographic Regions

+

MTE04.01 - Thoracic Cancers Research and Resource Disparities among Geographic Regions

+

PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

+

PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

+

PL02.02 - Discussant

+

PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

+

PL02.04 - Discussant

+

PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

+

PL02.06 - Discussant

+

PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

+

PL02.08 - Discussant

+

PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

+

PL02.10 - Discussant

+

PL02.11 - Live Discussion with Speakers

+

PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

+

PL02A.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

+

PL02A.02 - Discussant

+

PL02A.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

+

PL02A.04 - Discussant

+

PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

+

PL02A.06 - Discussant

+

PL02A.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

+

PL02A.08 - Discussant

+

PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

+

PL02A.10 - Discussant

+

PL02A.11 - Live Discussion with Speakers

+

WS02 - Early Career Workshop

+

WS02.01 - Introduction

+

WS02.02 - How to Maximize Success in Publications for JTO - Writing a Compelling Manuscript

+

WS02.03 - How to Create Your First Clinical Trial

+

WS02.04 - How to Create Programmatic Growth in the Community Setting

+

WS02.05 - How to Move to Different Positions/Areas of Practice/Research? How to Pivot Within Your Career?

+

WS02.06 - How to Get Promoted

+

WS02.07 - How to Establish International Collaborations/Navigating Large International Trials

+

WS02.08 - Breakout Rooms for Each Topic

Stay Connected